Hepatitis C is diagnosed through a two-step blood testing process: first an antibody screening test, then a confirmatory test that detects the virus itself. Most people only need a simple blood draw to get started, and results typically come back within a few days. Understanding what each test measures and what the results mean can help you make sense of the process if you’re being screened or following up on an unexpected result.
Who Should Get Tested
The CDC recommends that every adult aged 18 and older be screened for hepatitis C at least once in their lifetime. Pregnant women should be screened during each pregnancy. These are universal recommendations, meaning they apply even if you have no known risk factors or symptoms.
People with ongoing risk factors need more frequent testing. This includes anyone who currently injects drugs and shares needles or other equipment, as well as people on long-term hemodialysis. If you fall into one of these groups, periodic retesting is recommended regardless of previous negative results.
Step One: The Antibody Test
The first test checks your blood for antibodies your immune system produced in response to the hepatitis C virus. This is a standard blood draw, and rapid point-of-care versions exist that can give results in minutes.
A non-reactive (negative) result means no antibodies were found, and you’re considered not infected. No further testing is needed in most cases. However, there’s an important exception: antibodies take an average of 8 weeks to develop after exposure. If you were exposed recently and tested during this “window period,” the test could miss the infection. Immunocompromised individuals, including people with HIV or organ transplant recipients, can also get false-negative results because their immune systems may not produce enough antibodies to trigger a positive reading.
A reactive (positive) result means antibodies were detected, but it does not necessarily mean you have an active infection right now. A positive antibody test indicates one of three possibilities: you have a current active infection, you had hepatitis C in the past and your body cleared it or you were cured by treatment, or the result is a false positive. False positives can occur due to cross-reactivity with other viral proteins or autoimmune conditions like lupus or rheumatoid arthritis. This is why a second, confirmatory test is always needed.
Step Two: The RNA Test
If the antibody test comes back positive, the next step is an RNA test (also called a nucleic acid test). This test looks for the virus’s actual genetic material in your blood, confirming whether the virus is actively present and replicating. Many labs use a “reflex” system where a positive antibody result automatically triggers the RNA test on the same blood sample, so you may not need a second blood draw.
A positive RNA test confirms active hepatitis C infection. The test also measures your viral load, the amount of virus circulating in your blood. A negative RNA test after a positive antibody test means the virus is no longer in your system. You either cleared the infection on your own or were successfully treated in the past. Roughly 15 to 45% of people who contract hepatitis C clear the virus spontaneously without treatment. Their antibody test will remain positive for life, but they don’t have an active infection and don’t need treatment.
Telling Acute From Chronic Infection
Once active infection is confirmed, your doctor may need to determine whether the infection is new (acute) or longstanding (chronic). This distinction matters because a small percentage of acute infections resolve on their own, while chronic infections require treatment.
Acute hepatitis C is identified by a combination of clinical signs and lab evidence. Symptoms like jaundice, significantly elevated liver enzymes (ALT levels above 200 IU/L), or elevated bilirubin suggest a new infection, especially if there’s no other explanation for sudden liver inflammation. The strongest evidence is documented test conversion: a negative antibody or RNA test followed by a positive result within 12 months.
If the virus is still detectable one year or more after the initial acute episode, the infection is reclassified as chronic. Since most people with hepatitis C have no symptoms during the early phase, the majority of diagnoses are chronic infections discovered through routine screening.
Genotype Testing
After confirming active infection, a genotype test identifies which strain of the virus you carry. There are five major genotypes worldwide, and they differ in how they respond to treatment and how long treatment needs to last. The test works by amplifying the virus’s genetic material from your blood and matching it against known genetic sequences for each genotype, including subtypes like 1a and 1b.
Newer antiviral treatments are effective across multiple genotypes, which has made genotyping slightly less critical than it once was. Still, knowing your genotype helps your doctor choose the most targeted treatment regimen and predict how you’ll respond.
Assessing Liver Damage
Diagnosis doesn’t end with confirming the virus. Understanding how much liver damage has already occurred is a key part of the workup, since it influences treatment urgency and long-term monitoring.
Liver Stiffness Scans
The most common non-invasive method is transient elastography, often done with a device called FibroScan. It sends a painless wave through your liver and measures how fast the wave travels. Stiffer liver tissue (a sign of scarring) transmits the wave faster. Results are measured in kilopascals. Values above roughly 12.5 kPa typically indicate cirrhosis, though different studies place the threshold between 11 and 14 kPa. The scan takes about 10 minutes, requires 8 hours of fasting beforehand, and involves 10 measurements that are averaged for a final result. If the individual readings vary too widely (more than 30% spread), the result is considered unreliable and may need to be repeated.
Blood-Based Scoring
When a FibroScan isn’t available, doctors can estimate liver scarring using routine blood tests you’ve likely already had drawn. The two most common scores are APRI, which uses your AST liver enzyme level and platelet count, and FIB-4, which adds your age and a second liver enzyme to the calculation. The WHO recommends using two cutoff values for each score: a lower cutoff that’s good at ruling out significant scarring (sensitivity above 82%), and a higher cutoff that’s good at confirming it (specificity above 90%). These scores aren’t as precise as imaging, but they’re inexpensive and widely accessible.
Other elastography techniques built into newer ultrasound machines can also measure liver stiffness, giving doctors additional options depending on what equipment is available. Liver biopsy, once the gold standard, is now reserved for cases where non-invasive results are unclear or conflicting.
What to Expect From the Process
For most people, the entire diagnostic path from initial screening to a complete picture of their infection takes two to three appointments. The antibody test and RNA test may be handled from a single blood draw if your lab uses reflex testing. Genotype results and liver assessment typically follow within a couple of weeks. If all tests confirm active infection, you’ll have enough information to begin discussing treatment options, which now cure more than 95% of cases in 8 to 12 weeks of oral medication.